These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38643501)

  • 1. Letter: The enigma of angiotensin receptor blocker-associated enteropathy.
    Mohamedrashed M; Nedumannil L; Garg M
    Aliment Pharmacol Ther; 2024 Jun; 59(12):1636-1637. PubMed ID: 38643501
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: The enigma of angiotensin receptor blocker-associated enteropathy-Authors' reply.
    Schiepatti A; Maimaris S; Biagi F; Sanders DS
    Aliment Pharmacol Ther; 2024 Jun; 59(12):1638-1639. PubMed ID: 38709108
    [No Abstract]   [Full Text] [Related]  

  • 3. Olmesartan-induced enteropathy treated with budesonide.
    Kempenaers S; Bogaert J; De Maeyer M; Van Hauthem P; Ramael M; Schoeters P
    Acta Gastroenterol Belg; 2019; 82(2):319-321. PubMed ID: 31314195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe enteropathy with villous atrophy olmesartan medoxomil-associated].
    Nunge D; Eoche M; Fumery M; Nguyen-Khac E; Gras V; Andréjak M
    Therapie; 2013; 68(6):419-21. PubMed ID: 24246126
    [No Abstract]   [Full Text] [Related]  

  • 5. Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers.
    Schiepatti A; Minerba P; Puricelli M; Maimaris S; Arpa G; Biagi F; Sanders DS
    Aliment Pharmacol Ther; 2024 Feb; 59(4):432-444. PubMed ID: 38185985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sprue-like enteropathy due to olmesartan.
    Muñoz-Muñoz C; López-Vivancos J; Huaman W; García-Cors M
    Rev Esp Enferm Dig; 2015 Oct; 107(10):647-8. PubMed ID: 26437988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.
    Wenzel RR; Datz C
    Wien Klin Wochenschr; 2019 Oct; 131(19-20):493-501. PubMed ID: 31471672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study.
    You SC; Park H; Yoon D; Park S; Joung B; Park RW
    Korean J Intern Med; 2019 Jan; 34(1):90-98. PubMed ID: 29172402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Angiotensin Receptor Blockers and Risk of Alzheimer's Disease: A Class Effect?
    Mangoni AA; Jarmuzewska EA
    Curr Rev Clin Exp Pharmacol; 2021; 16(1):2-3. PubMed ID: 34528501
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spruelike enterothy associated with olmesartan].
    Curieses Luengo M; Barreiro Alonso E; Izquierdo Romero M; Román Llorente FJ
    Aten Primaria; 2017; 49(6):369-370. PubMed ID: 28117168
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: sprue-like enteropathy associated with angiotensin II receptor blockers other than olmesartan.
    Zanelli M; Negro A; Santi R; Bisagni A; Ragazzi M; Ascani S; De Marco L
    Aliment Pharmacol Ther; 2017 Aug; 46(4):471-473. PubMed ID: 28707802
    [No Abstract]   [Full Text] [Related]  

  • 12. Olmesartan-Induced Enteropathy.
    Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
    Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of clinical studies on angiotensin II receptor blockers and risk of cancer.
    Dézsi CA
    Int J Cardiol; 2014 Dec; 177(3):748-53. PubMed ID: 25465823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: sprue-like enteropathy associated with angiotensin II receptor blockers other than olmesartan-authors'reply.
    Marthey L; Carbonnel F
    Aliment Pharmacol Ther; 2017 Aug; 46(4):473-474. PubMed ID: 28707797
    [No Abstract]   [Full Text] [Related]  

  • 15. Enteropathy and intestinal malabsorption in patients treated with antihypertensive drugs.
    Lee SR; Lee EG; Cho YH; Park EJ; Lee YI; Choi JI; Kwon RJ; Son SM; Lee SY; Yi YH; Kim GL; Kim YJ; Lee JG; Tak YJ; Lee SH; Ra YJ
    Saudi Med J; 2024 Apr; 45(4):437-441. PubMed ID: 38657980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin receptor blockers and drug-drug interactions.
    Sica DA
    Expert Opin Drug Saf; 2005 Jan; 4(1):139-40. PubMed ID: 15709904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Abdominal Pain and Cutaneous Swelling.
    Sacco KA; Mousa OY; Wang MH
    Gastroenterology; 2017 Sep; 153(3):651-652. PubMed ID: 28780015
    [No Abstract]   [Full Text] [Related]  

  • 18. [Olmesartan-associated Enteropathy].
    Zou L; Wang Q; Li Y; Yang AM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Dec; 43(6):986-990. PubMed ID: 34980342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety concerns of angiotensin II receptor blockers in preschool children.
    Tullus K
    Arch Dis Child; 2011 Sep; 96(9):881-2. PubMed ID: 21690106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: telmisartan-associated enteropathy - is there any class effect?
    Cyrany J; Vasatko T; Machac J; Nova M; Szanyi J; Kopacova M
    Aliment Pharmacol Ther; 2014 Sep; 40(5):569-70. PubMed ID: 25103353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.